These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1675782

  • 21. Expression, purification, and characterization of Bacneu. A soluble protein tyrosine kinase domain encoded by the neu-oncogene.
    Myers JN, LeVea CM, Smith JE, Kallen RG, Tung L, Greene MI.
    Receptor; 1992; 2(1):1-16. PubMed ID: 1362129
    [Abstract] [Full Text] [Related]

  • 22. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
    Stern DF, Kamps MP, Cao H.
    Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
    [Abstract] [Full Text] [Related]

  • 23. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA, Stern DF.
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
    [Abstract] [Full Text] [Related]

  • 24. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
    Guy PM, Carraway KL, Cerione RA.
    J Biol Chem; 1992 Jul 15; 267(20):13851-6. PubMed ID: 1352772
    [Abstract] [Full Text] [Related]

  • 25. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    Stern DF, Kamps MP.
    EMBO J; 1988 Apr 15; 7(4):995-1001. PubMed ID: 3261240
    [Abstract] [Full Text] [Related]

  • 26. Repression of neu-induced clonogenicity by dimethylsulfoxide correlates with decreased levels of neu-encoded cell-surface p185 and changes in phosphotyrosine content of endogenous proteins.
    Matin A, Hung MC.
    Cancer Lett; 1993 Jan 15; 68(1):55-60. PubMed ID: 7678546
    [Abstract] [Full Text] [Related]

  • 27. Transactivation of the TPA-responsive element by the oncogenic C-erbB-2 protein is partly mediated by protein kinase C.
    Fujimoto A, Kai S, Akiyama T, Toyoshima K, Kaibuchi K, Takai Y, Yamamoto T.
    Biochem Biophys Res Commun; 1991 Jul 31; 178(2):724-32. PubMed ID: 1677566
    [Abstract] [Full Text] [Related]

  • 28. Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation.
    Epstein RJ, Druker BJ, Roberts TM, Stiles CD.
    J Biol Chem; 1990 Jun 25; 265(18):10746-51. PubMed ID: 1972380
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.
    Xu FJ, Boyer CM, Bae DS, Wu S, Greenwald M, O'Briant K, Yu YH, Mills GB, Bast RC.
    Int J Cancer; 1994 Oct 15; 59(2):242-7. PubMed ID: 7927925
    [Abstract] [Full Text] [Related]

  • 32. Nuclear pp64 is phosphorylated in both serine/threonine and tyrosine through complex pathways regulated by 12-O-tetradecanoylphorbol-13-acetate and platelet-derived growth factor.
    Shawver LK, Deuel TF.
    Biochem Biophys Res Commun; 1990 Mar 30; 167(3):918-26. PubMed ID: 2108677
    [Abstract] [Full Text] [Related]

  • 33. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.
    Epstein RJ, Druker BJ, Roberts TM, Stiles CD.
    Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10435-9. PubMed ID: 1359539
    [Abstract] [Full Text] [Related]

  • 34. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
    Samanta A, LeVea CM, Dougall WC, Qian X, Greene MI.
    Proc Natl Acad Sci U S A; 1994 Mar 01; 91(5):1711-5. PubMed ID: 7907421
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3.
    Zabrecky JR, Lam T, McKenzie SJ, Carney W.
    J Biol Chem; 1991 Jan 25; 266(3):1716-20. PubMed ID: 1671042
    [Abstract] [Full Text] [Related]

  • 37. Mutation of a protein kinase C phosphorylation site in the erbB protein of avian erythroblastosis virus.
    Decker SJ, Dorai B, Russell S.
    J Virol; 1988 Oct 25; 62(10):3649-54. PubMed ID: 2901498
    [Abstract] [Full Text] [Related]

  • 38. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
    Sottocornola E, Berra B, Colombo I.
    Biochim Biophys Acta; 2003 Dec 30; 1635(2-3):55-66. PubMed ID: 14729068
    [Abstract] [Full Text] [Related]

  • 39. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene.
    Boccaccio C, Gaudino G, Cilli M, Mondino A, Comoglio PM.
    Growth Factors; 1991 Dec 30; 5(3):233-42. PubMed ID: 1685656
    [Abstract] [Full Text] [Related]

  • 40. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
    Yarden Y.
    Proc Natl Acad Sci U S A; 1990 Apr 30; 87(7):2569-73. PubMed ID: 1969636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.